CytoDyn Inc. held annual shareholder meeting
CytoDyn Inc. held its 2025 Annual Meeting of Stockholders on November 21, 2025. Stockholders elected all nominated directors, approved CBIZ CPAs P.C. as the independent accounting firm, increased authorized shares from 1.75 billion to 2.25 billion, and approved an annual advisory vote on executive compensation.
CytoDyn Inc. held its 2025 Annual Meeting of Stockholders on November 21, 2025. Stockholders elected all nominated directors to the board. Approval was given for the selection of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending May 31, 2026. Stockholders also voted to increase the total number of authorized shares of common stock from 1,750,000,000 to 2,250,000,000. Additionally, stockholders approved holding an advisory vote on executive compensation every year. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoDyn Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-115056), on November 21, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
